Takada Y et al. |
Improvement of allograft viability with organs procured from non-heart-beating donors in porcine liver transplantation. |
2000 |
Transplant. Proc. |
pmid:10715416
|
Fukuoka T et al. |
Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion. |
1993 |
Transplant. Proc. |
pmid:8470175
|
Taniguchi S et al. |
Effects of a platelet-activating factor antagonist at different doses given simultaneously with double-filtration plasmapheresis on cardiac xenograft survival. |
1994 |
Transplant. Proc. |
pmid:8171719
|
Coughlan AF et al. |
In vivo studies of P-selectin and platelet activating factor during endotoxemia, accelerated allograft rejection, and discordant xenograft rejection. |
1993 |
Transplant. Proc. |
pmid:7692651
|
Hammer C et al. |
Xenogeneic rejection mechanisms shown by intravital microscopy. |
1998 |
Transplant. Proc. |
pmid:9865335
|
Takada Y et al. |
Energy metabolism of hepatic allografts subjected to prolonged warm ischemia and pharmacologic modulation with FK506 and platelet activating factor antagonist. |
1998 |
Transplant. Proc. |
pmid:9838621
|
Fukunaga K et al. |
Successful liver transplantation from non-heart-beating donors by blockade of endothelin and PAE. |
1998 |
Transplant. Proc. |
pmid:9838664
|
Lloberas N et al. |
The ether phospholipids trail: blood timing in renal ischemia-reperfusion injury. |
2002 |
Transplant. Proc. |
pmid:11959179
|
Castellvi J et al. |
Effect of the platelet-activating factor antagonist BN-52021 on liver preservation (4 degrees): experimental study in isolated reperfused rat liver model. |
2002 |
Transplant. Proc. |
pmid:11959181
|
Keskinoglu A et al. |
Inflammatory lipid mediators and immunologic recognition in allogeneic renal transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9122948
|
Otte KE et al. |
Xenoperfusion of rabbit kidney and the impact of BN 52021: a specific antagonist of platelet-activating factor. |
1990 |
Transplant. Proc. |
pmid:2349668
|
Foegh ML |
Eicosanoids and platelet activating factor mechanisms in organ rejection. |
1988 |
Transplant. Proc. |
pmid:3059615
|
Mahmoud FF et al. |
In vitro effects of ginkgolide B combined with cyclosporin A on T-lymphocyte activation and IL-5 expression in peripheral blood mononuclear cells from asthmatic subjects. |
2002 |
Transplant. Proc. |
pmid:12431672
|
Borobia FG et al. |
Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats. |
1993 |
Transplant. Proc. |
pmid:8356661
|
Da Costa M et al. |
Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170. |
1990 |
Transplant. Proc. |
pmid:2389490
|
Bergmann R et al. |
Effects of a PAF-antagonist (WEB 2086) on hyperacute xenogeneic rejection in ex vivo perfused kidneys. |
1990 |
Transplant. Proc. |
pmid:2389511
|
Renkonen R et al. |
Second messenger pathways in lymphocyte binding and penetration through graft vascular endothelium. |
1991 |
Transplant. Proc. |
pmid:1846709
|
O'Hair DP et al. |
Platelet activating factor antagonist RP-59227 reduces vascular injury in discordant cardiac xenograft rejection. |
1992 |
Transplant. Proc. |
pmid:1566490
|
|
First International Alexis Carrel Conference on Lipid Mediators in Organ Transplantation. April 8-10, 1986, Washington, DC. |
1986 |
Transplant. Proc. |
pmid:3765055
|
Minor T et al. |
Treatment of preservation/reperfusion injury by platelet-activating factor antagonism in the rat liver graft. |
1995 |
Transplant. Proc. |
pmid:7879086
|
Ide S et al. |
Donor administration of PAF antagonist (TCV-309) enhances lung preservation. |
1995 |
Transplant. Proc. |
pmid:7879103
|
Takada Y et al. |
Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7879169
|
Yin M et al. |
Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury. |
1995 |
Transplant. Proc. |
pmid:7879180
|
Hirt SW et al. |
Antagonisation of platelet activating factor--a new therapeutic concept for improvement of organ quality in lung preservation. |
1992 |
Transpl. Int. |
pmid:14621825
|
Torras J et al. |
Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model. |
1993 |
Transpl. Int. |
pmid:8347271
|
Räisänen A et al. |
Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo. |
1993 |
Transpl. Int. |
pmid:8216700
|
Shukla SD et al. |
Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity. |
1989 Jul-Aug |
Transfusion |
pmid:2546298
|
Guerrant RL et al. |
Diarrhea, demography and cell signaling: lessons from microbial toxins. |
1997 |
Trans. Am. Clin. Climatol. Assoc. |
pmid:9108674
|
Melo RC et al. |
Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. |
2005 |
Traffic |
pmid:16138901
|
Gambero A et al. |
Signalling pathways regulating human neutrophil migration induced by secretory phospholipases A2. |
2004 |
Toxicon |
pmid:15450921
|
Teixeira CF et al. |
Hyperalgesia induced by Bothrops jararaca venom in rats: role of eicosanoids and platelet activating factor (PAF). |
1994 |
Toxicon |
pmid:8052996
|
Shiroma N et al. |
Haemodynamic and haematologic effects of Acanthaster planci venom in dogs. |
1994 |
Toxicon |
pmid:7846692
|
Havt A et al. |
The renal effects of Bothrops jararacussu venom and the role of PLA(2) and PAF blockers. |
2001 |
Toxicon |
pmid:11600146
|
Castro-Faria-Neto HC et al. |
Pro-inflammatory activity of enterolobin: a haemolytic protein purified from seeds of the Brazilian tree Enterolobium contortisiliquum. |
1991 |
Toxicon |
pmid:1796477
|
Yara A et al. |
Cardiovascular effects of Acanthaster planci venom in the rat: possible involvement of PAF in its hypotensive effect. |
1992 |
Toxicon |
pmid:1440631
|
Rees RS et al. |
Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. |
1988 |
Toxicon |
pmid:3245050
|
Freire-Maia L and de Matos IM |
Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. |
1993 |
Toxicon |
pmid:8266352
|
Tai H et al. |
TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb. |
2004 |
Toxicon |
pmid:15501291
|
Grandoni KM et al. |
Trichothecene mycotoxins inhibit phosphoinositide hydrolysis in bovine platelets stimulated with platelet activating factor. |
1992 |
Toxicology |
pmid:1311467
|
Pearson JM et al. |
Neither platelet activating factor nor leukotrienes are critical mediators of liver injury after lipopolysaccharide administration. |
1997 |
Toxicology |
pmid:9231696
|
Flaherty MM et al. |
Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice. |
2012 |
Toxicol. Sci. |
pmid:22025730
|
Feuerstein G et al. |
Protective effect of a PAF-acether antagonist, BN 52021, in trichothecene toxicosis. |
1987 |
Toxicol. Lett. |
pmid:3660430
|
Bailie MB et al. |
Platelet activating factor receptor blockade alone or in combination with leukotriene synthesis inhibition does not ameliorate alpha-naphthylisothiocyanate-induced hepatotoxicity. |
1996 |
Toxicol. Lett. |
pmid:8614909
|
Mahgoub AA |
Thymoquinone protects against experimental colitis in rats. |
2003 |
Toxicol. Lett. |
pmid:12749817
|
Baskin SI et al. |
The effects of EDRF/NO releasers or calcium ionophore A23187 on cyanide toxicity in mice. |
1996 |
Toxicol. Appl. Pharmacol. |
pmid:8806852
|
Wright DT et al. |
Ozone stimulates release of platelet activating factor and activates phospholipases in guinea pig tracheal epithelial cells in primary culture. |
1994 |
Toxicol. Appl. Pharmacol. |
pmid:8048050
|
Nomura DK et al. |
Dual roles of brain serine hydrolase KIAA1363 in ether lipid metabolism and organophosphate detoxification. |
2008 |
Toxicol. Appl. Pharmacol. |
pmid:18164358
|
Samet JM and Friedman M |
Effect of ozone on platelet activating factor metabolism in phorbol-differentiated HL60 cells. |
1992 |
Toxicol. Appl. Pharmacol. |
pmid:1440609
|
Hanslik T et al. |
Effect of the platelet activating factor antagonist BN52021 in rabbits: role in gentamicin nephrotoxicity. |
1994 |
Toxicol. Appl. Pharmacol. |
pmid:8079343
|
Ramos G et al. |
Platelet activating factor receptor binding plays a critical role in jet fuel-induced immune suppression. |
2004 |
Toxicol. Appl. Pharmacol. |
pmid:15020195
|